124 related articles for article (PubMed ID: 1765863)
1. Blood testing for chronic beryllium disease.
Kreiss K; Newman LS; Mroz M
J Occup Med; 1991 Nov; 33(11):1188-9. PubMed ID: 1765863
[No Abstract] [Full Text] [Related]
2. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.
Markham TN
Int Arch Occup Environ Health; 1996; 68(6):405-7. PubMed ID: 8891776
[No Abstract] [Full Text] [Related]
3. Screening blood test identifies subclinical beryllium disease.
Kreiss K; Newman LS; Mroz MM; Campbell PA
J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
[TBL] [Abstract][Full Text] [Related]
4. Significance of the blood beryllium lymphocyte proliferation test.
Newman LS
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
[TBL] [Abstract][Full Text] [Related]
5. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
6. The BeLPT: algorithms and implications.
Middleton DC; Lewin MD; Kowalski PJ; Cox SS; Kleinbaum D
Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
[TBL] [Abstract][Full Text] [Related]
7. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
Deubner DC; Goodman M; Iannuzzi J
Appl Occup Environ Hyg; 2001 May; 16(5):521-6. PubMed ID: 11370932
[TBL] [Abstract][Full Text] [Related]
8. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
Williams WR; Williams WJ
Int Arch Allergy Appl Immunol; 1982; 67(2):175-80. PubMed ID: 7056594
[TBL] [Abstract][Full Text] [Related]
9. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
Newman LS; Kreiss K
Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
[TBL] [Abstract][Full Text] [Related]
10. Blood cell proliferation response to beryllium: analysis by receiver-operating characteristics.
Stokes RF; Rossman MD
J Occup Med; 1991 Jan; 33(1):23-8. PubMed ID: 1995798
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of beryllium lymphocyte proliferation testing.
Barna BP; Culver DA; Yen-Lieberman B; Dweik RA; Thomassen MJ
Clin Diagn Lab Immunol; 2003 Nov; 10(6):990-4. PubMed ID: 14607857
[No Abstract] [Full Text] [Related]
12. Beryllium-induced toxicity and its prevention by treatment with chelating agents.
Sharma P; Johri S; Shukla S
J Appl Toxicol; 2000; 20(4):313-8. PubMed ID: 10942906
[TBL] [Abstract][Full Text] [Related]
13. Reversible beryllium sensitization in a prospective study of beryllium workers.
Rom WN; Lockey JE; Bang KM; Dewitt C; Johns RE
Arch Environ Health; 1983; 38(5):302-7. PubMed ID: 6651355
[TBL] [Abstract][Full Text] [Related]
14. Optimizing BeLPT criteria for beryllium sensitization.
Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
[TBL] [Abstract][Full Text] [Related]
15. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
[TBL] [Abstract][Full Text] [Related]
16. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
Maier LA
Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of chronic berylliosis].
Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
[TBL] [Abstract][Full Text] [Related]
18. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
[TBL] [Abstract][Full Text] [Related]
19. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment.
Borak J; Woolf SH; Fields CA
J Occup Environ Med; 2006 Sep; 48(9):937-47. PubMed ID: 16966961
[TBL] [Abstract][Full Text] [Related]
20. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
